Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.35 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.35 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | MME | P08473 | 1/20 | 0.33 |
| ▸ | ACE | P12821 | 1/20 | 0.33 |
| ▸ | CPA1 | P15085 | 1/20 | 0.33 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6408902 | 1.00 | LDHA (0.35) | LDHASRRFFAR3MMEACE | |
| SCHEMBL6067688 | 0.79 | MME (0.42) | LDHASRRFFAR3MMEACE | |
| SCHEMBL6067684 | 0.79 | MME (0.42) | LDHASRRFFAR3MMEACE | |
| SCHEMBL4377302 | 0.78 | TSHR (0.38) | FFAR3TSHRTP53ALDH1A1TDP1 | |
| SCHEMBL13587629 | 0.78 | TSHR (0.38) | FFAR3TSHRTP53ALDH1A1TDP1 | |
| SCHEMBL1486226 | 0.78 | TSHR (0.38) | FFAR3TSHRTP53ALDH1A1TDP1 | |
| SCHEMBL6409374 | 0.78 | LDHA (0.40) | LDHASRRFFAR3TSHRTP53 | |
| SCHEMBL4382401 | 0.78 | TSHR (0.38) | FFAR3TSHRTP53ALDH1A1TDP1 | |
| SCHEMBL3440791 | 0.78 | LDHA (0.40) | LDHASRRFFAR3TSHRTP53 | |
| SCHEMBL13587627 | 0.78 | TSHR (0.38) | FFAR3TSHRTP53ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7807418-B2 | Method for producing hybrid polyketide synthases | BIOTICA TECHNOLOGY LIMITED (GB) | 2010-10-05 | — | — | US | disclosed |
| EP-0910633-B1 | Hybrid polyketide synthase I gene | BIOTICA TECH LTD (GB) | 2009-12-09 | — | — | EP | disclosed |
| US-20050089982-A1 | Polyketides and their synthesis | LEADLAY PETER F (GB) | 2005-04-28 | — | — | US | disclosed |
| US-6437151-B2 | FERMENTATION; CULTURE PRODUCT | BIOTICA TECHNOLOGY LIMITED (GB) | 2002-08-20 | — | — | US | disclosed |
| US-20020004487-A1 | Novel erythromycins and process for their preparation | BIOTICA TECHNOLOGY LIMITED (GB) | 2002-01-10 | — | — | US | disclosed |
| US-20010016598-A1 | Fermenting suitable organisms such as saccharopolyspora erythraea in the presence of a carboxylic acid | LEADLAY PETER FRANCIS (GB) | 2001-08-23 | — | — | US | disclosed |
| US-6271255-B1 | USEFUL AS ANTIBACTERIAL AND ANTIPROTOZOAL AGENTS IN INFECTIONS IN MAMMALS, FISH, AND BIRDS | BIOTICA TECHNOLOGY LIMITED (GB) | 2001-08-07 | — | — | US | disclosed |
| EP-0909327-A2 | ERYTHROMYCINS AND PROCESS FOR THEIR PREPARATION | Biotica Technology Limited (GB) | 1999-04-21 | — | — | EP | disclosed |
| WO-1998001571-A2 | ERYTHROMYCINS AND PROCESS FOR THEIR PREPARATION | BIOTICA TECHNOLOGY LIMITED (GB) | 1998-01-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004487-A1 | Novel erythromycins and process for their preparation | MRPL21, RPL13, RPS3A | LDHA 1665/4885SRR 119/4885FFAR3 1517/4885 |
| US-20010016598-A1 | Fermenting suitable organisms such as saccharopolyspora erythraea in the presence of a carboxylic acid | COASY, RPL13, DCXR | LDHA 196/4885SRR 109/4885FFAR3 487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.